Combined treatment with baicalein and paclitaxel may induce apoptosis of ovarian cancer cells by increasing the release of cytochrome c, activating Caspase-3/-9 and inhibiting the Akt/β-catenin pathway [9]. This evidence concerns the gene AKT1 and ovarian cancer.